TerminatedPhase 2NCT00816348
Compassionate Use of Omegaven IV Fat Emulsion
Studying Parenteral nutrition-associated cholestasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cindy Haller
- Principal Investigator
- Cindy Haller, MDCohen Children's Medical Center of New York
- Intervention
- Omegaven(drug)
- Enrollment
- 15 target
- Eligibility
- 5 years · All sexes
- Timeline
- 2008 – 2014
Study locations (2)
- Cohen Children's Medical Cenetr of New York at North Shore, Manhasset, New York, United States
- Cohen Children's Medical Center of New York, New Hyde Park, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00816348 on ClinicalTrials.govOther trials for Parenteral nutrition-associated cholestasis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06274788Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven TreatmentFresenius Kabi
- RECRUITINGPHASE4NCT06049680Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult PatientsFresenius Kabi
See all trials for Parenteral nutrition-associated cholestasis →